Platelet Aggregation Inhibitors: Clinical Trials

1 unknown. 1 Phase 4.

By phase and status

Phase	Trials	Status
Phase 4	1	Unknown 1

Follow Platelet Aggregation Inhibitors: new trials by email Literature Review of Platelet Aggregation Inhibitors trials Research Report on Platelet Aggregation Inhibitors

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study for the Patients With ACS 1-months DAPT, 12-month DAPT - Acute Coronary Syndrome, Acute Myocardial Infarction	Phase 4	Unknown	Kyoto University, Graduate School of Medicine	3008	2018-04-02	2024-06-14

Narrower conditions

Acute Coronary Syndrome (1)  ·  Coronary Artery Disease (1)

Broader conditions

Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Cardiovascular Diseases (1)  ·  Coronary Disease (1)  ·  Heart Diseases (1)  ·  Myocardial Ischemia (1)  ·  Vascular Diseases (1)

Interventions

2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine (1)

Sponsors

Kyoto University, Graduate School of Medicine (1)

Countries

Japan (1)

Top investigators

Takeshi Kimura, MD (1)

Results publications

PMID 35234821, PMID 35912647, PMID 36599584, PMID 36873770, PMID 41847750